Form 4 for CI Cigna
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001225208-23-002989 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | 2023-02-24 | CI | Eder Noelle K | EVP, Gbl CIO | F - Tax | $294.27 | -2,007 | 17.8K | -10% | -$590.6K | |
| 2023-02-28 | 2023-02-24 | CI | Eder Noelle K | EVP, Gbl CIO | A - Grant | $0.00 | +5,410 | 19.8K | +38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2023-02-24 | F | D | 2,007 | $294.27 | 17,769 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 2 | Common | Common Stock, $.01 Par Value | 2023-02-24 | A | A | 5,410 | $0.00 | 19,776 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |